Results 121 to 130 of about 1,235,795 (296)

Harnessing the power of artificial intelligence for disease-surveillance purposes

BMC Proceedings
The COVID-19 pandemic accelerated the development of AI-driven tools to improve public health surveillance and outbreak management. While AI programs have shown promise in disease surveillance, they also present issues such as data privacy, prejudice ...
Barbara Tornimbene, Zoila Beatriz Leiva Rioja, John Brownstein, Adam Dunn, Sylvain Faye, Jude Kong, Nada Malou, Clara Nordon, Benjamin Rader, Oliver Morgan   +9 more
doaj   +1 more source

Causes of Epidemics [PDF]

The Boston Medical and Surgical Journal
n ...
openaire   +2 more sources

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Mathematical modelling of zika virus in Brazil

, 2017
In this paper we study some deterministic mathematical models that seek to explain the expansion of zika virus, as a viral epidemic, using published data for Brazil.
Boret, Saúl E. Buitrago, Escalante, René, Villasana, Minaya   +2 more
core  

Zuranolone: A case study in (regulatory) rush to judgement?

British Journal of Clinical Pharmacology, EarlyView.
Abstract Sage, in collaboration with Biogen, submitted a new drug approval for zuranolone for postpartum depression (PPD) and major depressive disorder (MDD) in December 2022. In August 2023, the US Food and Drug Administration granted approval for PPD but denied approval for MDD.
Lisa Cosgrove, Milutin Kostic, Barbara Mintzes, Gianna D'Ambrozio, Allen Shaughnessy   +4 more
wiley   +1 more source

Informing social media analysis for public health: a cross-sectional survey of professionals

Archives of Public Health
Background During the COVID-19 pandemic, the field of infodemic management has grown in response to urgent global need. Social listening is the first step in managing the infodemic, and many organizations and health systems have implemented processes ...
Becky K. White, Elisabeth Wilhelm, Atsuyoshi Ishizumi, Surangani Abeyesekera, Alhassan Pereira, Brian Yau, Aleksandra Kuzmanovic, Tim Nguyen, Sylvie Briand, Tina D. Purnat   +9 more
doaj   +1 more source

Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection

Frontiers in Public Health
BackgroundHybrid immunity (a combination of natural and vaccine-induced immunity) provides additional immune protection against the coronavirus disease 2019 (COVID-19) reinfection.
Huiling Zheng, Huiling Zheng, Shenggen Wu, Wu Chen, Shaojian Cai, Meirong Zhan, Cailin Chen, Jiawei Lin, Zhonghang Xie, Jianming Ou, Wenjing Ye   +10 more
doaj   +1 more source

AN EPIDEMIC OF CHOREA [PDF]

The Journal of Nervous and Mental Disease, 1891
n ...
openaire   +1 more source

Do drugs approved via expedited approval pathways have therapeutic advantages? A systematic review and meta‐analysis

British Journal of Clinical Pharmacology, EarlyView.
Regulators use expedited approval pathways to speed market approval and patient access to promising new drugs. However, there is uncertainty about whether these pathways are successful in approving drugs with significant therapeutic advantages. This systematic review aims to examine the safety, effectiveness and cost‐effectiveness of drugs approved via
Ashleigh Hooimeyer, Eliza J. McEwin, Zhicheng Wang, Joel Lexchin, Barbara Mintzes   +4 more
wiley   +1 more source

Paeoniflorin Alleviates LPS-Induced Inflammation and Acute Myocardial Injury by Inhibiting PI3K/Akt/ERK-Mediated HIF-1α and TLR4/MyD88/NF-κB Inflammatory Signaling

Mediators of Inflammation
Sepsis-induced myocardial injury (SIMI) greatly increases the mortality rate of sepsis. Although paeoniflorin (PF) has been proven to improve survival in sepsis, the detailed mechanism of PF on SIMI remains elusive.
Xiaowu Guo, Zhiguang Han, Jiahuan Sun, Shupeng Liu, Chuang Zhang, Gengrui Xu, Xiaodan Wang, Qiuhang Song, Hongxia Yang, Aiying Li   +9 more
doaj   +1 more source